ArticleJournal of gastrointestinal cancer2026
Global, Regional, and National Burden of Liver Cancer Due to Alcohol Use, 1990-2021: a Systematic Analysis for the Global Burden of Disease Study 2021.
Article in Journal of gastrointestinal cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo estimate the global, regional, and national burden of liver cancer attributable to alcohol use from 1990 to 2021, and to project trends to 2050.
methodsSystematic analysis of GBD 2021 data covering 204 countries and territories, 21 regions, and 5 SDI quintiles. Numbers and age-standardised rates of deaths, DALYs, prevalence, and incidence were analysed. EAPC and AAPC quantified temporal trends; Spearman correlation, decomposition analysis, health inequality assessment, and efficiency frontier analysis were performed. ARIMA models projected trends to 2050.
resultsIn 2021, alcohol use accounted for 92,228 deaths (95% UI 75,053-112,160) and 2.32 million DALYs (95% UI 1.89-2.85 million) globally, with age-standardised mortality and DALY rates of 1.17 and 29.35 per 100,000. From 1990 to 2021, the age-standardised mortality, DALY, incidence, and prevalence rates all increased. The highest rates were observed in Western Europe, Australasia, and High-income Asia Pacific. High SDI regions had the greatest burden and the steepest increases, whereas Low SDI regions showed modest declines. SDI was positively correlated with all burden metrics. Population growth and aging were the primary drivers of increasing death counts, and the SII for mortality widened from 1990 to 2021. Mongolia had the largest avoidable burden.
conclusionThe global burden of alcohol-attributable liver cancer has increased substantially over three decades, with marked geographical and socioeconomic disparities.
Indexed as
Identifiers
42867754What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.